RxSight (RXST) FCF Margin Growth (3y) (2023 - 2026)
RxSight (RXST) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 60.00 |
| 10 | RxSight | 249.98 Mn | -154.26 Mn | - | 1,096.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,096.00 |
| Mar 31, 2026 | 6,534.00 |
| Dec 31, 2025 | 7,105.00 |
| Sep 30, 2025 | 12,760.00 |
| Jun 30, 2025 | 12,132.00 |
| Mar 31, 2025 | 14,787.00 |
| Dec 31, 2024 | 8,918.00 |
| Sep 30, 2024 | 21,600.00 |
| Jun 30, 2024 | 24,552.00 |
| Mar 31, 2024 | 27,035.00 |
| Dec 31, 2023 | -10,114.00 |
| Sep 30, 2023 | 13,244.00 |